Table 3.
The Role of Astragalus in Alleviating Liver and Lung Injury
| Disease | Administration and Dose | Experimental Models | Efficacy | Mechanism | Reference |
|---|---|---|---|---|---|
| Drug-induced liver injury | Mongolian astragalus polysaccharide 100 mg/kg for 14 d | Drug-induced liver injury induced by overdose of APAP intraperitoneal injection | Mongolian Astragalus polysaccharides can alleviate APAP-induced drug-induced liver injury | Nrf-2 and LC3Nrf-2, Keap-1 and their downstream target genes↑ MAPK, TNF-α, IL-6 and IL-1β↓ |
[37] |
| Liver damage | Astragalus injection 2 g/mL for 7 d | Adult healthy male Wistar rats | Relieves hepatocyte apoptosis and has a hepatoprotective effect | Bcl-2, Bcl-2/Bax↑ | [85] |
| Liver damage | AS-IV 20 and 40 mg/kg for 1 week | ICR clean-grade mice treated with AS-IV | AS-IV can significantly reduce the expression of inflammatory factors in mice with paracetamol-induced liver injury, and can play a certain therapeutic role in liver injury | TNF-α, IL-1β, IL-6↓ | [86] |
| Liver damage | AS-IV 80 mg/kg for 8 weeks | With AS-IV 80 mg/kg) and Metformin, Met; 120 mg/kg) separately treated in T2DMSD rats | AS-IV has a certain protective effect on liver injury in T2DM | Liver index, serum HOMA-IR, serum TNF-α, IL-6 levels↓ AMPK/mTOR pathway↑ |
[87] |
| Oxidative damage to hepatic stellate cells | 100 and 200 μmol/L AS-IV for 36 h | Hepatic stellate cells | Astragaloside pretreatment attenuates oxidative damage to rat hepatic stellate cells | Cell viability↑ Apoptotic cells, intracellular Caspase-3 and Caspase-9 expression levels, ROS levels↓ |
[88] |
| Acute liver injury | Astragalus extract 350 mg/kg for 12 h | Normal mice were treated with Astragalus extract and modeled 3 days after prophylactic administration of Astragalus extract | Astragalus extract has anti-APAP acute liver injury effects | Apoptosis-related genes MAPK14, CAT, ALT, AST↓ | [89] |
| Liver fibrosis and liver injury | Astragalus wt> 99.5%) Compound soft-shelled turtle soft liver tablets, 9 weeks |
Healthy mice were injected subcutaneously with corn oil solution containing 20% CCl4 at a dose of 6 mL/kg twice a week to establish a rat model of liver fibrosis injury | Astragalus has an effective protective effect on liver injury in experimental liver fibrosis rats through the p38MAPK signaling pathway | The expression of ALT, AST and TBIL, p38MAPK, MKK3 and ATF-2 proteins in serum↓ | [90] |